A phase II trial of gefitinib and concurrent radiation therapy for locally advanced non-small cell lung cancer patients harboring sensitive EGFR mutations.
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000003274
- Lead Sponsor
- ational Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with active severe infections 2.Significant interstitial pneumonitis , pulmonary fibrosis on Chest CT 3.Contralateral hilar lymph node metastasis 4.Patietns with ileus 5.Patients with uncontrollable diarrhea 6.The presence of other concomitant cancers 7.Serious allergy history 8.Patients with total gastrectomy 9.Heavy smoking habit: (the number of cigarettes smoked daily) x (smoking period)> 400 10.Tumor infiltrating great vessels clearly 11.Patients harboring T790M mutation 12.Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method